Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)
CUSIP: 05280R100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
- Shares outstanding
- 265,957,447
- Total 13F shares
- 165,944,662
- Share change
- -2,043,961
- Total reported value
- $378,376,899
- Price per share
- $2.28
- Number of holders
- 93
- Value change
- +$9,844,394
- Number of buys
- 51
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05280R100:
Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
10%
|
27,091,700
|
$41,992,135 | — | 31 Mar 2025 | |
| Syncona Portfolio Ltd |
13D/G
13F
|
Syncona Portfolio Limited · Company |
11%
|
28,821,053
|
$37,755,579 | $0 | 31 Mar 2025 | |
| Blackstone Inc. |
13F
|
Company |
7.7%
|
20,485,611
|
$31,752,697 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
6.7%
|
17,849,482
|
$27,666,697 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
4.1%
|
11,000,000
|
$17,050,000 | — | 31 Mar 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
3.8%
from 13D/G
|
10,162,348
|
$15,751,639 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.7%
|
9,910,642
|
$15,361,495 | — | 31 Mar 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
3.2%
|
8,600,000
|
$13,330,000 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.7%
|
4,623,324
|
$7,166,152 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.5%
|
3,944,834
|
$6,114,494 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.4%
|
3,608,490
|
$5,990,093 | — | 31 Mar 2025 | |
| Laurion Capital Management LP |
13F
|
Company |
1.3%
|
3,369,248
|
$5,222,335 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
3,191,401
|
$4,946,686 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
1.2%
|
3,126,167
|
$4,845,559 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.1%
|
3,045,000
|
$4,719,750 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
2,900,186
|
$4,496,000 | — | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1%
|
2,728,910
|
$4,229,811 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
1,986,190
|
$3,078,594 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.6%
|
1,584,125
|
$2,455,394 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.53%
|
1,410,104
|
$2,185,661 | — | 31 Mar 2025 | |
| Perpetual Ltd |
13F
|
Company |
0.46%
|
1,223,743
|
$1,896,802 | — | 31 Mar 2025 | |
| Alphabet Inc. |
13F
|
Company |
0.26%
|
698,262
|
$1,082,306 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.23%
|
619,913
|
$960,866 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.22%
|
586,667
|
$909,334 | — | 31 Mar 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.2%
|
524,872
|
$813,552 | — | 31 Mar 2025 | |
| Atle Fund Management AB |
13F
|
Company |
0.18%
|
479,644
|
$743,448 | — | 31 Mar 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.16%
|
420,000
|
$651,000 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
395,443
|
$612,937 | — | 31 Mar 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.15%
|
386,001
|
$598,302 | — | 31 Mar 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.13%
|
343,947
|
$533,118 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
316,227
|
$490,152 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
309,576
|
$479,843 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.11%
|
299,836
|
$463,247 | — | 31 Mar 2025 | |
| EDENTREE ASSET MANAGEMENT Ltd |
13F
|
Company |
0.11%
|
300,000
|
$462,000 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.1%
|
261,146
|
$404,776 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
256,515
|
$397,598 | — | 31 Mar 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.09%
|
251,674
|
$390,094 | — | 31 Mar 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.07%
|
195,000
|
$323,700 | — | 31 Mar 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
199,709
|
$309,549 | — | 31 Mar 2025 | |
| BIT Capital GmbH |
13F
|
Company |
0.07%
|
199,359
|
$309,006 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
188,908
|
$292,807 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
164,700
|
$255,285 | — | 31 Mar 2025 | |
| Vident Advisory, LLC |
13F
|
Company |
0.06%
|
155,504
|
$241,032 | — | 31 Mar 2025 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.05%
|
138,783
|
$215,114 | — | 31 Mar 2025 | |
| Aubrey Capital Management Ltd |
13F
|
Company |
0.05%
|
119,998
|
$197,021 | — | 31 Mar 2025 | |
| NEOS Investment Management LLC |
13F
|
Company |
0.04%
|
110,428
|
$171,163 | — | 31 Mar 2025 | |
| TEMA ETFS LLC |
13F
|
Company |
0.04%
|
110,428
|
$171,163 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
102,493
|
$158,864 | — | 31 Mar 2025 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0.03%
|
91,107
|
$141,216 | — | 31 Mar 2025 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
0.03%
|
89,949
|
$139,421 | — | 31 Mar 2025 |
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q2 2025
As of 30 Jun 2025,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
165,944,662 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Blackstone Inc., MAK CAPITAL ONE LLC, Deep Track Capital, LP, Syncona Portfolio Ltd, ARMISTICE CAPITAL, LLC, TFG Asset Management GP Ltd, FMR LLC, Frazier Life Sciences Management, L.P., and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
93
Q2 2025 holders
93
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.